Family nurse practitioner Carol Ramsubhag-Carela prepares a syringe with the Mpox vaccine before inoculating a patient at a vaccinations site on Tuesday, Aug. 30, 2022, in the Brooklyn borough of New York. Africa's public health body said Thursday, Feb. 16, 2023 it hopes Mpox vaccines will finally arrive on the continent "in another two weeks, tops" after months of seeking doses. (AP Photo/Jeenah Moon, File)
An 18-member panel has recommended that adults at risk of contracting mpox should be vaccinated as a precaution.
The Centers for Disease and Control still needs to decide whether or not the agency will accept the recommendation, but if it does, adults over the age of 18 would be advised to get vaccinated.
"The recent outbreak has highlighted again the risks that infectious diseases can present to our communities, the importance of a robust public health response at the state and local level, the value of engaged partners and communities in responding to public health threats and the impact that a vaccine can have in helping bring an outbreak under control," Dr. Melinda Wharton, the CDC associate director for vaccine policy, told CNN.
The vote comes after an mpox outbreak swept the U.S. in the summer of 2022 and popped up in other countries where no cases had been reported for decades.
The Jynneos mpox vaccine, which is a two-dose treatment, has an efficacy rate of 83 percent and was approved for emergency use in August when nearly 450 new cases were being reported daily. The highest reported cases were among sexually active gay and bisexual men.
While the amount of daily reported cases has dwindled drastically since the previous summer — down to just two per day — it is still higher than what the U.S. reported in recent years.
"We do not think that this outbreak is over, and that's very important to keep in mind," Dr. Agam Rao, medical officer in the CDC's Division of High Consequence Pathogens and Pathology, said.
On Monday, football fans were stunned when Buffalo Bills safety Damar Hamlin collapsed and suffered cardiac arrest. Cheddar News explains the condition and the steps to take if you witness an incident.
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
Join Cheddar News as we break down the top headlines this morning including updates on the Jan. 6 hears, the PGA suspension of 17 of the world's best golfers, and NASA's plans to study UFOs.
Rick Pauls, President & CEO OF DiaMedica Therapeutics, joins Cheddar Innovates to discuss a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients.
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
